Profound Medical Corp.
Profound Medical Corp. builds MRI‑guided, transurethral ultrasound ablation systems for prostate tissue, used by urologists and radiologists treating prostate cancer and BPH. Its FDA‑cleared TULSA‑PRO platform is sold to hospitals and outpatient centers with associated disposables, software, and service contracts. Founded in 2008 and headquartered in Mississauga, Ontario, the company is publicly traded and focuses on image‑guided, incision‑free prostate ablation workflows.
Open Positions at Profound Medical Corp.
2 open positions
Senior Software Developer building embedded and Windows-based therapy software for advanced medical ablation systems. The role spans real-time hardware-adjacent components, clinical desktop applications, and automated testing.
The Senior Software Developer will design and deliver enterprise-grade software in a highly regulated medical device environment, with deep expertise in WPF and complex business logic. The role combines architecture, hands-on development, testing, responsible use of AI tools, and mentorship.